FI951078A0 - Retrovirusinfektion inhibitio - Google Patents

Retrovirusinfektion inhibitio

Info

Publication number: FI951078A0
Authority: FI; Finland
Prior art keywords: inhibition; retroviral infection; slpi; prevention; methods
Prior art date: 1992-09-09

Application number

FI951078A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI951078A (fi

Inventor

Stephen Eisenberg

Sharon M Wahl

Robert C Thompson

Original Assignee

Amgen Boulder Inc

Us Health

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-09

Filing date

1995-03-08

Publication date

1995-03-08

1995-03-08 Application filed by Amgen Boulder Inc, Us Health filed Critical Amgen Boulder Inc

1995-03-08 Publication of FI951078A publication Critical patent/FI951078A/fi

1995-03-08 Publication of FI951078A0 publication Critical patent/FI951078A0/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
AIDS & HIV (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FI951078A 1992-09-09 1995-03-08 Retrovirusinfektion inhibitio FI951078A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94336992A	1992-09-09	1992-09-09
PCT/US1993/008486 WO1994006454A2 (en)	1992-09-09	1993-09-09	Inhibitiion of retrovirus infection

Publications (2)

Publication Number	Publication Date
FI951078A FI951078A (fi)	1995-03-08
FI951078A0 true FI951078A0 (fi)	1995-03-08

Family

ID=25479533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI951078A FI951078A0 (fi)	1992-09-09	1995-03-08	Retrovirusinfektion inhibitio

Country Status (23)

Country	Link
EP (1)	EP0666755B1 (de)
JP (2)	JP3517238B2 (de)
KR (1)	KR100273620B1 (de)
AT (1)	ATE238062T1 (de)
AU (1)	AU681350B2 (de)
CA (1)	CA2141951C (de)
CZ (1)	CZ286953B6 (de)
DE (1)	DE69332904T2 (de)
DK (1)	DK0666755T3 (de)
ES (1)	ES2197153T3 (de)
FI (1)	FI951078A0 (de)
HU (1)	HU218892B (de)
NO (1)	NO315546B1 (de)
NZ (1)	NZ256246A (de)
OA (1)	OA10133A (de)
PL (1)	PL307864A1 (de)
PT (1)	PT666755E (de)
RO (1)	RO116164B1 (de)
RU (1)	RU2126266C1 (de)
SG (1)	SG48115A1 (de)
SK (1)	SK281127B6 (de)
UA (1)	UA41338C2 (de)
WO (1)	WO1994006454A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5900401A (en) *	1994-03-23	1999-05-04	Tokyo Tanabe Company Limited	Remedy for respiratory-tract viral disease
WO1997003694A1 (fr) *	1995-07-24	1997-02-06	Tokyo Tanabe Company Limited	Remede contre les affections virales
US6270808B1 (en)	1995-11-13	2001-08-07	Gerard Voerman	Anti-viral isolates obtainable from leeches
US7276333B1 (en)	1999-05-13	2007-10-02	Japan Science And Technology Agency	Viral infection inhibitor targeting integrase N-terminal domain
DE10101792B4 (de) *	2001-01-17	2004-03-18	Vivotec Biomedical Technologies Gmbh	Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
US8288439B2 (en)	2003-11-04	2012-10-16	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for the inhibition of HIV-1 replication

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340877C (en) *	1987-12-28	2000-01-18	Takashi Sugiyama	Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) *	1988-11-28	1998-09-30	日本ケミカルリサーチ株式会社	エイズ治療および阻害剤
CA2007083A1 (en) *	1989-01-09	1990-07-09	Nobuhiko Katunuma	Pharmaceutical use of trypstatin
ES2097766T3 (es) *	1989-08-16	1997-04-16	Chiron Corp	Composiciones para la inhibicion de la formacion de hormonas proteicas y sus usos.
JPH05502868A (ja) *	1989-12-18	1993-05-20	トランスジーンソシエテアノニム	レトロウィルス感染症を治療又は予防する薬学的組成物
GR1001044B (el) *	1991-06-03	1993-04-28	Logothetou Rella Eleni	Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

1993
- 1993-09-09 SG SG1996007118A patent/SG48115A1/en unknown
- 1993-09-09 EP EP93921439A patent/EP0666755B1/de not_active Expired - Lifetime
- 1993-09-09 KR KR1019950700929A patent/KR100273620B1/ko not_active IP Right Cessation
- 1993-09-09 AT AT93921439T patent/ATE238062T1/de not_active IP Right Cessation
- 1993-09-09 JP JP50816294A patent/JP3517238B2/ja not_active Expired - Fee Related
- 1993-09-09 DE DE69332904T patent/DE69332904T2/de not_active Expired - Fee Related
- 1993-09-09 SK SK297-95A patent/SK281127B6/sk unknown
- 1993-09-09 HU HU9500682A patent/HU218892B/hu not_active IP Right Cessation
- 1993-09-09 UA UA95048317A patent/UA41338C2/uk unknown
- 1993-09-09 AU AU48530/93A patent/AU681350B2/en not_active Ceased
- 1993-09-09 CA CA002141951A patent/CA2141951C/en not_active Expired - Fee Related
- 1993-09-09 RU RU95109909A patent/RU2126266C1/ru not_active IP Right Cessation
- 1993-09-09 PT PT93921439T patent/PT666755E/pt unknown
- 1993-09-09 PL PL93307864A patent/PL307864A1/xx unknown
- 1993-09-09 CZ CZ1995559A patent/CZ286953B6/cs not_active IP Right Cessation
- 1993-09-09 WO PCT/US1993/008486 patent/WO1994006454A2/en active IP Right Grant
- 1993-09-09 NZ NZ256246A patent/NZ256246A/xx not_active IP Right Cessation
- 1993-09-09 DK DK93921439T patent/DK0666755T3/da active
- 1993-09-09 RO RO95-00493A patent/RO116164B1/ro unknown
- 1993-09-09 ES ES93921439T patent/ES2197153T3/es not_active Expired - Lifetime
1995
- 1995-03-08 FI FI951078A patent/FI951078A0/fi not_active Application Discontinuation
- 1995-03-08 NO NO19950897A patent/NO315546B1/no unknown
- 1995-03-09 OA OA60622A patent/OA10133A/en unknown
2003
- 2003-07-07 JP JP2003271629A patent/JP2004002455A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
RU2126266C1 (ru)	1999-02-20
AU4853093A (en)	1994-04-12
FI951078A (fi)	1995-03-08
NO315546B1 (no)	2003-09-22
WO1994006454A3 (en)	1994-08-18
ES2197153T3 (es)	2004-01-01
DK0666755T3 (da)	2003-08-04
PL307864A1 (en)	1995-06-26
WO1994006454A2 (en)	1994-03-31
EP0666755B1 (de)	2003-04-23
RU95109909A (ru)	1997-03-27
RO116164B1 (ro)	2000-11-30
HUT75126A (en)	1997-04-28
JP2004002455A (ja)	2004-01-08
EP0666755A1 (de)	1995-08-16
NO950897L (no)	1995-03-08
SK281127B6 (sk)	2000-12-11
JP3517238B2 (ja)	2004-04-12
OA10133A (en)	1996-12-18
JPH08505042A (ja)	1996-06-04
HU218892B (hu)	2000-12-28
CZ55995A3 (en)	1996-01-17
CZ286953B6 (en)	2000-08-16
CA2141951A1 (en)	1994-03-31
ATE238062T1 (de)	2003-05-15
CA2141951C (en)	2007-04-24
UA41338C2 (uk)	2001-09-17
HU9500682D0 (en)	1995-04-28
NO950897D0 (no)	1995-03-08
PT666755E (pt)	2003-09-30
KR100273620B1 (ko)	2000-12-15
AU681350B2 (en)	1997-08-28
DE69332904D1 (de)	2003-05-28
SG48115A1 (en)	1998-04-17
DE69332904T2 (de)	2003-11-06
SK29795A3 (en)	1997-02-05
NZ256246A (en)	1997-08-22
KR950703357A (ko)	1995-09-20

Publication	Publication Date	Title
BG102048A (en)	1998-08-31	Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MX9706913A (es)	1997-11-29	Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
ATE193304T1 (de)	2000-06-15	Inhibitoren der menschlichen neutrophilenelastase
NO932620L (no)	1994-01-21	Amindiol-proteaseinhibitorer
DK0951473T3 (da)	2002-09-16	Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
NO983688L (no)	1998-10-12	Serin-protease-inhibitorer
MX9706947A (es)	1997-11-29	Inhibidores de proteasa retroviral de sulfonilalcanoilamino-hidroxietilamino-sulfonamida y uso de los mismos.
NO962017L (no)	1996-07-08	5,6-Dihydropyron - derivater som protease-inhibitorer og antivirus-midler
NO974147D0 (no)	1997-09-09	Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease
CA2136331A1 (en)	1993-12-09	New pharmaceutical uses of krill enzymes
NO983991L (no)	1998-10-30	Serin-protease-inhibitorer
MD960172A (en)	1999-01-31	5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
FI951078A0 (fi)	1995-03-08	Retrovirusinfektion inhibitio
DE69624105D1 (de)	2002-11-07	Inhibitoren der metazoenparasiten-proteasen
MX9304351A (es)	1994-02-28	Inhibidores de proteasas de aminodiol y composiciones farmaceuticas que los incluyen.
GEP19991605B (en)	1999-04-29	Inhibitor, Its Obtaining and Use
MX9706912A (es)	1998-01-31	Inhibidores de protesa retroviral de sulfonamida de hidroxietilamino de amino acido y uso de los mismos.
RU93055681A (ru)	1996-12-27	Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях

Legal Events

Date	Code	Title	Description
1995-07-18	FD	Application lapsed
2005-09-18	FD	Application lapsed